TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Systematic Case Series Study Investigating the Effectiveness of Eye Movement Desensitization Reprocessing (EMDR) in the Treatment of Childhood Sexual Abuse in Adolescents and Adult Survivors
Brief Summary: This study investigates the effectiveness of EMDR for survivors of childhood sexual abuse. All participants will undertake a standard course of EMDR via the National Heath Service program, alongside a number of questionnaires and a follow-up interview.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Processing Therapy | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy, Behavioral: Hypnosis | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: Hypnosis; Assigned to Arm(s): 2
B: Arm Label: CBT for PTSD; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy for PTSD | Arm Label: Imagery Rehearsal Therapy + CBT for PTSD; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy for PTSD, Behavioral: Imagery Rehearsal Therapy | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy for PTSD; Assigned to Arm(s): CBT for PTSD, Imagery Rehearsal Therapy + CBT for PTSD | Intervention Type: BEHAVIORAL; Name: Imagery Rehearsal Therapy; Assigned to Arm(s): Imagery Rehearsal Therapy + CBT for PTSD
C: Arm Label: Eye Movement Desensitization Reprocessing (EMDR); Type: EXPERIMENTAL; Interventions: Behavioral: Eye Movement Desensitization Reprocessing (EMDR) | Intervention Type: BEHAVIORAL; Name: Eye Movement Desensitization Reprocessing (EMDR); Assigned to Arm(s): Eye Movement Desensitization Reprocessing (EMDR)
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: TF-CBT | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment as Usual (TAU) | Intervention Type: OTHER; Name: TF-CBT; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Treatment as Usual (TAU); Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Systematic Case Series Study Investigating the Effectiveness of Eye Movement Desensitization Reprocessing (EMDR) in the Treatment of Childhood Sexual Abuse in Adolescents and Adult Survivors
Brief Summary: This study investigates the effectiveness of EMDR for survivors of childhood sexual abuse. All participants will undertake a standard course of EMDR via the National Heath Service program, alongside a number of questionnaires and a follow-up interview.


Options:
A: Arm Label: Trauma Center Trauma-Sensitive Yoga (TCTSY); Type: EXPERIMENTAL; Interventions: Behavioral: Trauma Center Trauma Sensitive Yoga Intervention (TCTSY) | Arm Label: Cognitive Processing Therapy (CPT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Processing Therapy | Intervention Type: BEHAVIORAL; Name: Trauma Center Trauma Sensitive Yoga Intervention (TCTSY); Assigned to Arm(s): Trauma Center Trauma-Sensitive Yoga (TCTSY) | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): Cognitive Processing Therapy (CPT)
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Cognitive Behavioral Treatment for Insomnia (CBT-I) | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Cognitive Behavioral Treatment for Insomnia (CBT-I); Assigned to Arm(s): 1
C: Arm Label: Eye Movement Desensitization Reprocessing (EMDR); Type: EXPERIMENTAL; Interventions: Behavioral: Eye Movement Desensitization Reprocessing (EMDR) | Intervention Type: BEHAVIORAL; Name: Eye Movement Desensitization Reprocessing (EMDR); Assigned to Arm(s): Eye Movement Desensitization Reprocessing (EMDR)
D: Arm Label: Control - VSLA; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Control - Mental Health; Type: OTHER; Interventions: Behavioral: Treatment as usual | Arm Label: Voluntary Savings/Loans Assoc; Type: EXPERIMENTAL; Interventions: Behavioral: Voluntary Savings/Loans Assoc | Arm Label: Cognitive Processing Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): Control - Mental Health | Intervention Type: BEHAVIORAL; Name: Voluntary Savings/Loans Assoc; Assigned to Arm(s): Voluntary Savings/Loans Assoc | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): Cognitive Processing Therapy

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: 2018 Intern Health Study Micro-randomized Trial: Developing a Mobile Health App to Improve Mental Health and Maintain Healthy Behaviors During the Internship Year
Brief Summary: The aim of this trial is to evaluate the efficacy of an intervention (delivered through a smartphone) for improving the mood, physical activity, and sleep of medical interns.


Options:
A: Arm Label: Mobile Video Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Stress management counseling | Arm Label: Offline Counseling; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Stress management counseling | Arm Label: Selfcare; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Stress management counseling; Assigned to Arm(s): Mobile Video Counseling, Offline Counseling
B: Arm Label: Transcendental Meditation Intervention Arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Transcendental Meditation | Arm Label: Treatment as usual(TAU) Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Transcendental Meditation; Assigned to Arm(s): Transcendental Meditation Intervention Arm
C: Arm Label: Within-participant Micro-randomization; Type: EXPERIMENTAL; Interventions: Behavioral: Intern Health Study behavioral change mobile notification, Behavioral: Intern Health Study mobile app | Arm Label: No intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Intern Health Study mobile app | Intervention Type: BEHAVIORAL; Name: Intern Health Study behavioral change mobile notification; Assigned to Arm(s): Within-participant Micro-randomization | Intervention Type: BEHAVIORAL; Name: Intern Health Study mobile app; Assigned to Arm(s): No intervention, Within-participant Micro-randomization
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Corporate Athlete Resilience (CAR) Training Program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Corporate Athlete Resilience (CAR) Training Program; Assigned to Arm(s): Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mobile Methods for Reducing Obesity Risk in Parents and Children: A Randomized Trial
Brief Summary: The purpose of this study is to test the efficacy of an innovative 6-month smartphone-delivered intervention using simplified monitoring of dietary intake compared to a smartphone-delivered intervention with standard calorie monitoring among parents with overweight or obesity.


Options:
A: Arm Label: Simple; Type: EXPERIMENTAL; Interventions: Behavioral: Simple | Arm Label: Standard; Type: EXPERIMENTAL; Interventions: Behavioral: Standard | Intervention Type: BEHAVIORAL; Name: Simple; Assigned to Arm(s): Simple | Intervention Type: BEHAVIORAL; Name: Standard; Assigned to Arm(s): Standard
B: Arm Label: RIDE; Type: EXPERIMENTAL; Interventions: Behavioral: RIDE e-health application | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: RIDE e-health application; Assigned to Arm(s): RIDE
C: Arm Label: Mobile Technology Plus (MT+); Type: EXPERIMENTAL; Interventions: Behavioral: Mobile Technology Plus | Arm Label: Mobile Technology (MT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mobile Technology | Intervention Type: BEHAVIORAL; Name: Mobile Technology Plus; Assigned to Arm(s): Mobile Technology Plus (MT+) | Intervention Type: BEHAVIORAL; Name: Mobile Technology; Assigned to Arm(s): Mobile Technology (MT)
D: Arm Label: Standard; Type: EXPERIMENTAL; Interventions: Behavioral: Standard | Arm Label: Technology Supported condition; Type: EXPERIMENTAL; Interventions: Behavioral: Technology Supported | Arm Label: Self-Guided; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Technology Supported; Assigned to Arm(s): Technology Supported condition | Intervention Type: BEHAVIORAL; Name: Standard; Assigned to Arm(s): Standard

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications (The Nudge Study)
Brief Summary: The study plans to learn if sending different text messages, serving as reminders or encouragement, may help patients take their medication more often if they have had trouble keeping up with their medicines.


Options:
A: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Generic Nudge; Type: EXPERIMENTAL; Interventions: Behavioral: Nudge | Arm Label: Optimized nudge; Type: EXPERIMENTAL; Interventions: Behavioral: Nudge | Arm Label: Optimized nudge plus AI Chat Bot; Type: EXPERIMENTAL; Interventions: Behavioral: Nudge | Intervention Type: BEHAVIORAL; Name: Nudge; Assigned to Arm(s): Generic Nudge, Optimized nudge, Optimized nudge plus AI Chat Bot
B: Arm Label: SINEMA intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: SINEMA intervention | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SINEMA intervention; Assigned to Arm(s): SINEMA intervention group
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: SMS reminders of medicines intake | Intervention Type: BEHAVIORAL; Name: SMS reminders of medicines intake; Assigned to Arm(s): Intervention
D: Arm Label: self-care promotion; Type: EXPERIMENTAL; Interventions: Other: Multifaceted strategy based on sending text messages(SMS) | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual outpatient care | Intervention Type: OTHER; Name: Multifaceted strategy based on sending text messages(SMS); Assigned to Arm(s): self-care promotion | Intervention Type: OTHER; Name: Usual outpatient care; Assigned to Arm(s): Control group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications (The Nudge Study)
Brief Summary: The study plans to learn if sending different text messages, serving as reminders or encouragement, may help patients take their medication more often if they have had trouble keeping up with their medicines.


Options:
A: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Device: "COMBINED STRATEGY" | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: "COMBINED STRATEGY"; Assigned to Arm(s): Intervention group
B: Arm Label: Weekly SMS, brief message; Type: EXPERIMENTAL; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Arm Label: Daily SMS, Brief message; Type: EXPERIMENTAL; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Arm Label: Daily SMS, Long Message; Type: EXPERIMENTAL; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Arm Label: Weekly SMS, Long Message; Type: EXPERIMENTAL; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Intervention Type: BEHAVIORAL; Name: Short Message Services to Support ARV therapy adherence; Assigned to Arm(s): Control Group, Daily SMS, Brief message, Daily SMS, Long Message, Weekly SMS, Long Message, Weekly SMS, brief message
C: Arm Label: Intensive BP control; Type: EXPERIMENTAL; Interventions: Drug: Intensive BP control | Arm Label: Standard BP control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard BP control | Intervention Type: DRUG; Name: Intensive BP control; Assigned to Arm(s): Intensive BP control | Intervention Type: DRUG; Name: Standard BP control; Assigned to Arm(s): Standard BP control
D: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Generic Nudge; Type: EXPERIMENTAL; Interventions: Behavioral: Nudge | Arm Label: Optimized nudge; Type: EXPERIMENTAL; Interventions: Behavioral: Nudge | Arm Label: Optimized nudge plus AI Chat Bot; Type: EXPERIMENTAL; Interventions: Behavioral: Nudge | Intervention Type: BEHAVIORAL; Name: Nudge; Assigned to Arm(s): Generic Nudge, Optimized nudge, Optimized nudge plus AI Chat Bot

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Additional Core Stability Exercises on Improving Dynamic Sitting Balance, Trunk Control and Functional Rehabilitation for Subacute Stroke Patients: A Randomized Controlled Trial
Brief Summary: This study assess the effectiveness of core stability exercises performed in subacute phase of stroke. Half of participants will receive conventional physiotherapy, while the other half will receive core stability exercises and core stability exercises plus transcutaneous electrical nerve stimulation (TENS).


Options:
A: Arm Label: Experimental Group; Type: EXPERIMENTAL; Interventions: Behavioral: Together in Movement and Exercise (TIME) Program | Arm Label: Wait-listed Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Together in Movement and Exercise (TIME) Program; Assigned to Arm(s): Experimental Group
B: Arm Label: Active tDCS + robotic therapy + physical therapy; Type: ACTIVE_COMPARATOR; Interventions: Device: Robotic Therapy, Device: Active tDCS, Other: Physical Therapy | Arm Label: sham tDCS + robotic therapy + physical therapy; Type: ACTIVE_COMPARATOR; Interventions: Device: Robotic Therapy, Device: Sham tDCS, Other: Physical Therapy | Arm Label: sham tDCS + physical therapy + occupational therapy; Type: EXPERIMENTAL; Interventions: Device: Sham tDCS, Other: Physical Therapy, Other: Occupational Therapy | Intervention Type: DEVICE; Name: Robotic Therapy; Assigned to Arm(s): Active tDCS + robotic therapy + physical therapy, sham tDCS + robotic therapy + physical therapy | Intervention Type: DEVICE; Name: Active tDCS; Assigned to Arm(s): Active tDCS + robotic therapy + physical therapy | Intervention Type: DEVICE; Name: Sham tDCS; Assigned to Arm(s): sham tDCS + physical therapy + occupational therapy, sham tDCS + robotic therapy + physical therapy | Intervention Type: OTHER; Name: Physical Therapy; Assigned to Arm(s): Active tDCS + robotic therapy + physical therapy, sham tDCS + physical therapy + occupational therapy, sham tDCS + robotic therapy + physical therapy | Intervention Type: OTHER; Name: Occupational Therapy; Assigned to Arm(s): sham tDCS + physical therapy + occupational therapy
C: Arm Label: Core stability exercises; Type: EXPERIMENTAL; Interventions: Other: Core stability exercises (CSE), Other: Conventional Physiotherapy | Arm Label: Conventional physiotherapy (CP); Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional Physiotherapy | Intervention Type: OTHER; Name: Core stability exercises (CSE); Assigned to Arm(s): Core stability exercises | Intervention Type: OTHER; Name: Conventional Physiotherapy; Assigned to Arm(s): Conventional physiotherapy (CP), Core stability exercises
D: Arm Label: transcranial direct current stim; Type: EXPERIMENTAL; Interventions: Device: transcranial direct current stim (tDCS) | Arm Label: sham tDCS; Type: PLACEBO_COMPARATOR; Interventions: Device: transcranial direct current stim (tDCS) | Intervention Type: DEVICE; Name: transcranial direct current stim (tDCS); Assigned to Arm(s): sham tDCS, transcranial direct current stim

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation: a Double-blinded Randomized Controlled Trial
Brief Summary: The purpose of this study is to assess whether short-term (48 hr) tocolysis reduces perinatal morti-morbidity in cases of PPROM at 22 to 33 completed weeks' gestation.


Options:
A: Intervention Type: DRUG; Name: indomethacin; Assigned to Arm(s): N/A
B: Arm Label: Utrogestan; Type: ACTIVE_COMPARATOR; Interventions: Drug: utrogestan | Arm Label: Nifedipine; Type: PLACEBO_COMPARATOR; Interventions: Drug: Nifedipine | Intervention Type: DRUG; Name: utrogestan; Assigned to Arm(s): Utrogestan | Intervention Type: DRUG; Name: Nifedipine; Assigned to Arm(s): Nifedipine
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Magnesium sulfate | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oral Nifedipine or placebo | Intervention Type: DRUG; Name: Magnesium sulfate; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Oral Nifedipine or placebo; Assigned to Arm(s): 2
D: Arm Label: Nifedipine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nifedipine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo of Nifedipine | Intervention Type: DRUG; Name: Nifedipine; Assigned to Arm(s): Nifedipine | Intervention Type: DRUG; Name: Placebo of Nifedipine; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY)
Brief Summary: The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics (PK), and antidrug antibody (ADA) response for MEDI8897 in healthy late preterm and term infants who are 35 weeks or greater gestational age and entering their first RSV season.


Options:
A: Arm Label: RSVpreF vaccine; Type: EXPERIMENTAL; Interventions: Biological: RSVpreF | Arm Label: Placebo dose; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: RSVpreF; Assigned to Arm(s): RSVpreF vaccine | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo dose
B: Arm Label: MEDI8897; Type: EXPERIMENTAL; Interventions: Drug: MEDI8897 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: MEDI8897; Assigned to Arm(s): MEDI8897 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Palivizumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Palivizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Palivizumab; Assigned to Arm(s): Palivizumab | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: MEDI8897; Type: EXPERIMENTAL; Interventions: Drug: MEDI8897 | Arm Label: Palivizumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Palivizumab | Intervention Type: DRUG; Name: MEDI8897; Assigned to Arm(s): MEDI8897 | Intervention Type: DRUG; Name: Palivizumab; Assigned to Arm(s): Palivizumab

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Randomized, Multicenter, Open-Label, Pilot Study to Investigate Medication Adherence & Patient Reported Symptom Occurrence & Interference w/ Daily Life Comparing Envarsus XR® & Immediate Release Tacrolimus in Adult Renal Transplant Recipients (SIMPLE)
Brief Summary: The purpose of this study is to compare once-daily tacrolimus extended-release (Envarsus XR®) to twice-daily immediate release tacrolimus to find out if people taking tacrolimus extended release (Envarsus XR®) report fewer side effects, increased medication compliance and higher scores on quality of life assessments compared to people taking twice daily tacrolimus immediate release.


Options:
A: Arm Label: With Med-O-Wheel™; Type: N/A; Interventions: N/A | Arm Label: With out Med-O-Wheel™; Type: N/A; Interventions: N/A
B: Arm Label: Tacrolimus twice-daily; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tacrolimus twice daily | Arm Label: Envarsus XR; Type: ACTIVE_COMPARATOR; Interventions: Drug: Envarsus XR | Intervention Type: DRUG; Name: Envarsus XR; Assigned to Arm(s): Envarsus XR | Intervention Type: DRUG; Name: Tacrolimus twice daily; Assigned to Arm(s): Tacrolimus twice-daily
C: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: mHealth Intervention; Type: EXPERIMENTAL; Interventions: Other: mHealth Intervention | Intervention Type: OTHER; Name: mHealth Intervention; Assigned to Arm(s): mHealth Intervention
D: Arm Label: Patient education program; Type: EXPERIMENTAL; Interventions: Behavioral: Patient education program | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Patient education program; Assigned to Arm(s): Patient education program

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comprehensive Health Informatics Engagement Framework for Pulmonary Rehab
Brief Summary: Previous studies clearly established clinical benefits of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease however uptake and completion rate of pulmonary rehabilitation programs by these patients is limited by multiple barriers. The goal of this project to systematically evaluate impact of Comprehensive Health Informatics Engagement Framework for Pulmonary Rehabilitation (CHIEF-PR) in a randomized controlled trial. The main hypothesis is that CHIEF-PR will result in significantly higher rates of completion of a comprehensive pulmonary rehabilitation program.


Options:
A: Arm Label: 1: i-DSMP; Type: EXPERIMENTAL; Interventions: Behavioral: Internet DSMP | Arm Label: 2: f-DSMP; Type: EXPERIMENTAL; Interventions: Behavioral: Face-to-Face Dyspnea Self-management | Arm Label: 3: AC; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Attention Control | Intervention Type: BEHAVIORAL; Name: Internet DSMP; Assigned to Arm(s): 1: i-DSMP | Intervention Type: BEHAVIORAL; Name: Face-to-Face Dyspnea Self-management; Assigned to Arm(s): 2: f-DSMP | Intervention Type: BEHAVIORAL; Name: Attention Control; Assigned to Arm(s): 3: AC
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Telerehabilitation | Intervention Type: BEHAVIORAL; Name: Telerehabilitation; Assigned to Arm(s): Intervention
C: Arm Label: Best available care (BAC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Best available care (BAC) | Arm Label: Telerehabilitation (TH); Type: EXPERIMENTAL; Interventions: Behavioral: Telerehabilitation (TH) | Intervention Type: BEHAVIORAL; Name: Best available care (BAC); Assigned to Arm(s): Best available care (BAC) | Intervention Type: BEHAVIORAL; Name: Telerehabilitation (TH); Assigned to Arm(s): Telerehabilitation (TH)
D: Arm Label: CHF patients, IVR-Enhanced Care; Type: EXPERIMENTAL; Interventions: Behavioral: IVR-Enhanced Care | Arm Label: COPD patients, IVR-Enhanced Care; Type: EXPERIMENTAL; Interventions: Behavioral: IVR-Enhanced Care | Arm Label: CHF patients, Usual Discharge Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: COPD patients, Usual Discharge Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: IVR-Enhanced Care; Assigned to Arm(s): CHF patients, IVR-Enhanced Care, COPD patients, IVR-Enhanced Care

Answer: C